News

Part of Bunkerhill’s Carebricks platform, Bunkerhill BMD helps care teams identify and navigate follow-up for patients at risk of osteoporosis—using scans already in the system, with no added radiation or workflow disruption.

Bunkerhill Health and Cleerly are joining forces to expand access to AI-powered cardiovascular diagnostics, enabling earlier detection and personalized treatment of coronary artery disease. By integrating their FDA-cleared technologies, the partnership helps health systems identify at-risk patients and streamline care coordination for improved outcomes.

Bunkerhill Health announces the launch of Carebricks, an AI-powered platform that identifies clinically significant findings in medical images and reports, prioritizes follow-up needs, and automates care coordination. By integrating with electronic health records (EHRs), Carebricks ensures timely intervention for at-risk patients while reducing manual workload for care teams.

Meet Doug - a vegetable breeder from Gilroy, CA, whose severe coronary artery calcification went unreported for years before he received the care he needed. Through use of our early detection algorithms like Bunkerhill iCAC and Bunkerhill AVC, we aim to ensure that patients like Doug don't slip through the cracks.

Bunkerhill expands its health-system-wide solutions by providing cardiovascular care teams with AI-powered detection and quantification of aortic valve calcification on Non-Cardiac Chest CT to enable early disease detection.